147 related articles for article (PubMed ID: 31717764)
1. Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines.
Bonaccorsi PM; Labbozzetta M; Barattucci A; Salerno TMG; Poma P; Notarbartolo M
Pharmaceuticals (Basel); 2019 Oct; 12(4):. PubMed ID: 31717764
[TBL] [Abstract][Full Text] [Related]
2. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH
Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780
[TBL] [Abstract][Full Text] [Related]
3. NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers.
Poma P; Labbozzetta M; D'Alessandro N; Notarbartolo M
OMICS; 2017 Apr; 21(4):225-231. PubMed ID: 28388298
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles.
Jung KH; Lee JH; Park JW; Kim DH; Moon SH; Cho YS; Lee KH
Oncol Lett; 2018 Jun; 15(6):9093-9100. PubMed ID: 29805641
[TBL] [Abstract][Full Text] [Related]
5. H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells.
Pandolfi L; Bellini M; Vanna R; Morasso C; Zago A; Carcano S; Avvakumova S; Bertolini JA; Rizzuto MA; Colombo M; Prosperi D
Biomacromolecules; 2017 Oct; 18(10):3318-3330. PubMed ID: 28886247
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues.
Li Q; Chen J; Luo S; Xu J; Huang Q; Liu T
Eur J Med Chem; 2015 Mar; 93():461-9. PubMed ID: 25728027
[TBL] [Abstract][Full Text] [Related]
7. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells).
Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P
Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532
[TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells.
Coker-Gurkan A; Celik M; Ugur M; Arisan ED; Obakan-Yerlikaya P; Durdu ZB; Palavan-Unsal N
Amino Acids; 2018 Aug; 50(8):1045-1069. PubMed ID: 29770869
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anticancer action of quercetin and curcumin against triple-negative breast cancer cell lines.
Kundur S; Prayag A; Selvakumar P; Nguyen H; McKee L; Cruz C; Srinivasan A; Shoyele S; Lakshmikuttyamma A
J Cell Physiol; 2019 Jul; 234(7):11103-11118. PubMed ID: 30478904
[TBL] [Abstract][Full Text] [Related]
10. Curcumin and paclitaxel induce cell death in breast cancer cell lines.
Calaf GM; Ponce-Cusi R; Carrión F
Oncol Rep; 2018 Oct; 40(4):2381-2388. PubMed ID: 30066930
[TBL] [Abstract][Full Text] [Related]
11. Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells.
Jin R; Xia Y; Chen Q; Li W; Chen D; Ye H; Zhao C; Du X; Shi D; Wu J; Liang G
Drug Des Devel Ther; 2016; 10():979-95. PubMed ID: 27042000
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
13. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
14. Novel Curcumin Inspired Antineoplastic 1-Sulfonyl-4-Piperidones: Design, Synthesis and Molecular Modeling Studies.
Fawzy NG; Panda SS; Fayad W; El-Manawaty MA; Srour AM; Girgis AS
Anticancer Agents Med Chem; 2019; 19(8):1069-1078. PubMed ID: 30961509
[TBL] [Abstract][Full Text] [Related]
15. STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.
Kuo WY; Hwu L; Wu CY; Lee JS; Chang CW; Liu RS
Theranostics; 2017; 7(3):647-663. PubMed ID: 28255357
[TBL] [Abstract][Full Text] [Related]
16. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
[TBL] [Abstract][Full Text] [Related]
17. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
Kang HJ; Lee SH; Price JE; Kim LS
Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin.
Yadav B; Taurin S; Rosengren RJ; Schumacher M; Diederich M; Somers-Edgar TJ; Larsen L
Bioorg Med Chem; 2010 Sep; 18(18):6701-7. PubMed ID: 20728364
[TBL] [Abstract][Full Text] [Related]
19. Ultra-microsecond pulsed curcumin for effective treatment of triple negative breast cancers.
Mittal L; Raman V; Camarillo IG; Sundararajan R
Biochem Biophys Res Commun; 2017 Sep; 491(4):1015-1020. PubMed ID: 28780353
[TBL] [Abstract][Full Text] [Related]
20. Next-generation proteasome inhibitor oprozomib enhances sensitivity to doxorubicin in triple-negative breast cancer cells.
Shi Y; Bieerkehazhi S; Ma H
Int J Clin Exp Pathol; 2018; 11(5):2347-2355. PubMed ID: 31938346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
